G

GCM Medical Group, PSC | San Juan, PR

Research site
(Unclaimed)
Location
Urb. Floral Park, #62 Calle Jose Marti, San Juan, Puerto Rico, United States of America
Site insights

Top conditions

Arthritis (5 trials)

Psoriatic Arthritis (3 trials)

Rheumatoid Arthritis (2 trials)

Psoriasis (2 trials)

Rheumatic Diseases (2 trials)

Top treatments

Upadacitinib
Adalimumab
VX-147
ABT-494
CC-10004
Cenerimod
ABBV-105
AMG 451
Rocatinlimab
Apremilast

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

6 of 13
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus (OPUS-2)

The goal of this clinical trial is to see how well cenerimod is in reducing symptoms of Systemic Lupus Erythematous in adult patients with moderate t...

Enrolling
Lupus Erythematosus, Systemic
Drug: Cenerimod
Drug: Placebo

This study includes two periods. The main objective of Period 1 is to compare the efficacy of upadacitinib 15 mg once daily (QD) and 30 mg QD versus...

Active, not recruiting
Psoriatic Arthritis
Drug: Adalimumab
Drug: Placebo to Adalimumab

The study objectives of Period 1 are to compare the efficacy, safety, and tolerability of upadacitinib 15 mg once daily (QD) and 30 mg QD versus plac...

Active, not recruiting
Psoriatic Arthritis
Drug: Placebo
Drug: Upadacitinib

This clinical study will evaluate the safety, tolerability, and reactogenicity of 2 dose levels of messenger RNA (mRNA)-1893 Zika vaccine in comparis...

Active, not recruiting
Zika Virus
Biological: Placebo
Biological: mRNA-1893

The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy and combination therapy treatment in adolescent subje...

Enrolling
Atopic Dermatitis
Drug: Placebo
Drug: Rocatinlimab

The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants...

Enrolling
Proteinuric Kidney Disease
Drug: VX-147
Drug: Placebo

Trial sponsors

AbbVie logo

AbbVie (6 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems